| Serial Number | 98978174 |
| Word Mark | EXPEDITION |
| Filing Date | Friday, October 4, 2024 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, June 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 16, 2025 |
| Goods and Services | Pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; protein-based and small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders; protein-based and small molecule pharmaceuticals for the treatment, prevention, mitigation, management, or diagnosis of cancer, and viral, bacterial, fungal, parasitic, prion-based, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system-related, autoimmune, genetic, rare, hematological, musculoskeletal, rheumatological, renal, nutritional, otolaryngological, pediatric, developmental, age-related, and pain-related diseases and disorders |
| Goods and Services | Scientific research, namely, research and analysis services for the design and characterization of chemical therapeutic products; research services in the fields of proteomic analysis; proteomic analysis for scientific and research purposes; medical and scientific research in the field of proteomics; research and development in the field of proteomics; medical research, namely, compiling data for research purposes in the field of proteomics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 4, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, May 26, 2025 |
| First Use In Commerce Date | Monday, May 26, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 4, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, October 22, 2025 |
| First Use In Commerce Date | Wednesday, October 22, 2025 |
| Party Name | EXPEDITION MEDICINES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02142 US |
| Party Name | EXPEDITION MEDICINES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02142 US |
| Party Name | Flagship Labs 94, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 US |
| Event Date | Event Description |
| Friday, October 4, 2024 | NEW APPLICATION ENTERED |
| Wednesday, March 5, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, April 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, April 9, 2025 | ASSIGNED TO EXAMINER |
| Thursday, May 1, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, May 1, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, May 1, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 31, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 31, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 31, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 10, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 16, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 16, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 11, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, December 11, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 11, 2025 | SOU EXTENSION 1 FILED |
| Thursday, December 11, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, December 11, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, December 12, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 2, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, December 11, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Thursday, December 11, 2025 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, May 26, 2026 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, December 10, 2025 | SOU EXTENSION 2 FILED |
| Tuesday, May 26, 2026 | SOU EXTENSION 2 GRANTED |
| Thursday, December 11, 2025 | USE AMENDMENT FILED |
| Tuesday, May 26, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, May 27, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 10, 2026 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, June 10, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, June 10, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |